CADLX | JCRAX | CADLX / JCRAX | |
Total Expense Ratio | 0.77 | 1.41 | 55% |
Annual Report Gross Expense Ratio | 0.77 | 1.46 | 53% |
Fund Existence | 11 years | 15 years | - |
Gain YTD | 2.391 | 1.989 | 120% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 2500 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 242M | 901M | 27% |
Annual Yield % from dividends | 7.90 | 2.60 | 304% |
Returns for 1 year | 2.14 | -2.02 | -106% |
Returns for 3 years | -10.36 | -17.13 | 60% |
Returns for 5 years | 92.32 | 92.67 | 100% |
Returns for 10 years | 30.72 | 30.70 | 100% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
PPH | 82.01 | 1.73 | +2.15% |
VanEck Pharmaceutical ETF | |||
SPD | 33.85 | 0.65 | +1.96% |
Simplify US Equity PLUS Dwnsd Cnvxty ETF | |||
UCC | 35.30 | 0.66 | +1.91% |
ProShares Ultra Consumer Discretionary | |||
FIXD | 42.97 | -0.06 | -0.14% |
First Trust TCWOpportunistic Fxd Inc ETF | |||
WIA | 8.06 | -0.03 | -0.37% |
Western Asset Inflation-Linked Income Fund |